Trisomy 18 Syndrome clinical trials
The registry lists 28 studies for Trisomy 18 Syndrome across more than 10 countries. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-10-29.
Get an email when these change. Save the Trisomy 18 Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Natera, Inc. (8) · Sequenom, Inc. (4) · Progenity, Inc. (3) · Women and Infants Hospital of Rhode Island (2) · Lenetix Medical Screening Laboratory (1) · CHU de Quebec-Universite Laval (1) · BillionToOne Inc. (1) · Assiut University (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Nov 2027Hematological Profile in Children With Numerical Chromosomal Disorders · Assiut University
Who these studies take
Of the 1 Trisomy 18 Syndrome studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 1 (100%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (100%) | 0 (0%) |
| 18 | 1 (100%) | 0 (0%) |
| 30 | 1 (100%) | 0 (0%) |
| 40 | 1 (100%) | 0 (0%) |
| 50 | 1 (100%) | 0 (0%) |
| 65 | 1 (100%) | 0 (0%) |
| 75 | 1 (100%) | 0 (0%) |
| 85 | 1 (100%) | 0 (0%) |
Across all 28 studies, recruiting or not: 25% stop at 75 or younger and 25% at 65; 18% take children; 79% are for women only and 0% for men only; 46% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 28 of 28. search them.
- Hematological Profile in Children With Numerical Chromosomal DisordersNot yet recruitingNCT07807540
- The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk AssessmentRecruitingNCT076438961 country
- Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin PregnanciesCompletedNCT050043371 country
- Evaluation of Fetal Bladder Emptying During the 11-14 Weeks' Ultrasound Examination as a Negative Predictive Marker for Chromosomal AbnormalitiesActive, not recruitingNCT071657431 country
- Prenatal Non-invasive Aneuploidy Test Utilizing SNPs TrialTerminatedNCT015456746 countries
- VAlidation of a Lower Cost aneUploidy scrEenCompletedNCT030873573 countries
- SNP-based Microdeletion and Aneuploidy RegisTry (SMART)CompletedNCT023814576 countries
- Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal BloodCompletedNCT018527083 countries
- Whole Blood Specimen Collection From Pregnant SubjectsStatus unknownNCT024305841 country
- Feasibility Study of a New Screening Program for Major Aneuploidies (T21, T18, T13) in the Emilia-Romagna Region (SAPERER)Status unknownNCT044379921 country
- Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin PregnanciesCompletedNCT03200041Not applicable1 country
- Non-Invasive Chromosomal Evaluation of Trisomy StudyCompletedNCT022018621 country
- Multiple Gestation StudyCompletedNCT022785363 countries
- Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNACompletedNCT021097701 country
- Expanded Noninvasive Genomic Medical Assessment: The Enigma StudyCompletedNCT027874861 country
- High Risk Multiple Gestation StudyCompletedNCT022788741 country
- Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)Status unknownNCT035593741 country
- Non-Invasive Screening for Fetal AneuploidyStatus unknownNCT023179651 country
- Serum Sample Collection to Determine Analytical Performance Characteristics of the ADVIA Centaur PAPPA and BhCG AssaysCompletedNCT036297951 country
- Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal BloodCompletedNCT01925742Not applicable1 country
- Prenatal Screening for Down Syndrome With DNAFirstCompletedNCT019669911 country
- Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation PregnanciesTerminatedNCT022263151 country
- Comparison of Aneuploidy Risk EvaluationsCompletedNCT016633501 country
- Non-invasive Prenatal Diagnostic Validation StudyCompletedNCT015747811 country
- Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma MarkerCompletedNCT009713342 countries
- Non-Invasive Screening for Fetal AneuploidyCompletedNCT008479901 country
- Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma MarkerCompletedNCT007704581 country
- Non-Invasive Determination of Fetal Chromosome AbnormalitiesStatus unknownNCT008918521 country